P886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL

Bibliographic Details
Title: P886: EFFICACY, SURVIVAL AND SAFETY OF SELINEXOR, BORTEZOMIB AND DEXAMETHASONE (SVD) IN PATIENTS WITH LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: SUBGROUP DATA FROM THE BOSTON TRIAL
Authors: Maria-Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella Mesa, Holger W. Auner, Michele Cavo, Meletios A. Dimopoulos, Martina Bianco, Giovanni Marino Merlo, Charles la Porte, Philippe Moreau
Source: HemaSphere, Vol 7, p e1470834 (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the blood and blood-forming organs
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000970448.14708.34; https://doaj.org/toc/2572-9241
DOI: 10.1097/01.HS9.0000970448.14708.34
Access URL: https://doaj.org/article/6e69c4b2eda348199fa1356514f6eff2
Accession Number: edsdoj.6e69c4b2eda348199fa1356514f6eff2
Database: Directory of Open Access Journals
More Details
ISSN:25729241
DOI:10.1097/01.HS9.0000970448.14708.34
Published in:HemaSphere
Language:English